ALDOA_HUMAN - dbPTM
ALDOA_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID ALDOA_HUMAN
UniProt AC P04075
Protein Name Fructose-bisphosphate aldolase A
Gene Name ALDOA
Organism Homo sapiens (Human).
Sequence Length 364
Subcellular Localization Cytoplasm, myofibril, sarcomere, I band. Cytoplasm, myofibril, sarcomere, M line. In skeletal muscle, accumulates around the M line and within the I band, colocalizing with FBP2 on both sides of the Z line in the absence of Ca(2+)..
Protein Description Plays a key role in glycolysis and gluconeogenesis. In addition, may also function as scaffolding protein (By similarity)..
Protein Sequence MPYQYPALTPEQKKELSDIAHRIVAPGKGILAADESTGSIAKRLQSIGTENTEENRRFYRQLLLTADDRVNPCIGGVILFHETLYQKADDGRPFPQVIKSKGGVVGIKVDKGVVPLAGTNGETTTQGLDGLSERCAQYKKDGADFAKWRCVLKIGEHTPSALAIMENANVLARYASICQQNGIVPIVEPEILPDGDHDLKRCQYVTEKVLAAVYKALSDHHIYLEGTLLKPNMVTPGHACTQKFSHEEIAMATVTALRRTVPPAVTGITFLSGGQSEEEASINLNAINKCPLLKPWALTFSYGRALQASALKAWGGKKENLKAAQEEYVKRALANSLACQGKYTPSGQAGAAASESLFVSNHAY
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
3Phosphorylation-----MPYQYPALTP
-----CCCCCCCCCH
21.2727273156
5Phosphorylation---MPYQYPALTPEQ
---CCCCCCCCCHHH
5.6627273156
9PhosphorylationPYQYPALTPEQKKEL
CCCCCCCCHHHHHHH
27.2119664994
13AcetylationPALTPEQKKELSDIA
CCCCHHHHHHHHHHH
46.7016916647
13MalonylationPALTPEQKKELSDIA
CCCCHHHHHHHHHHH
46.7026320211
13SuccinylationPALTPEQKKELSDIA
CCCCHHHHHHHHHHH
46.7023954790
13UbiquitinationPALTPEQKKELSDIA
CCCCHHHHHHHHHHH
46.70-
14AcetylationALTPEQKKELSDIAH
CCCHHHHHHHHHHHH
64.6830583241
14MalonylationALTPEQKKELSDIAH
CCCHHHHHHHHHHHH
64.6826320211
14UbiquitinationALTPEQKKELSDIAH
CCCHHHHHHHHHHHH
64.6821890473
17PhosphorylationPEQKKELSDIAHRIV
HHHHHHHHHHHHHHH
28.2320068231
28AcetylationHRIVAPGKGILAADE
HHHHCCCCCEEEEEC
41.5426051181
28UbiquitinationHRIVAPGKGILAADE
HHHHCCCCCEEEEEC
41.5421890473
36PhosphorylationGILAADESTGSIAKR
CEEEEECCHHHHHHH
38.3229255136
37PhosphorylationILAADESTGSIAKRL
EEEEECCHHHHHHHH
32.6629255136
39PhosphorylationAADESTGSIAKRLQS
EEECCHHHHHHHHHH
21.3319664994
42SumoylationESTGSIAKRLQSIGT
CCHHHHHHHHHHHCC
52.55-
42AcetylationESTGSIAKRLQSIGT
CCHHHHHHHHHHHCC
52.5519608861
42MalonylationESTGSIAKRLQSIGT
CCHHHHHHHHHHHCC
52.5526320211
42SumoylationESTGSIAKRLQSIGT
CCHHHHHHHHHHHCC
52.5519608861
42UbiquitinationESTGSIAKRLQSIGT
CCHHHHHHHHHHHCC
52.5520639865
46PhosphorylationSIAKRLQSIGTENTE
HHHHHHHHHCCCCCH
27.8129255136
49PhosphorylationKRLQSIGTENTEENR
HHHHHHCCCCCHHHH
25.1330266825
52PhosphorylationQSIGTENTEENRRFY
HHHCCCCCHHHHHHH
38.1423927012
53 (in isoform 2)Phosphorylation-65.9330622161
56MethylationTENTEENRRFYRQLL
CCCCHHHHHHHHHHH
33.11-
57PhosphorylationENTEENRRFYRQLLL
CCCHHHHHHHHHHHH
44.5227642862
57 (in isoform 2)Phosphorylation-44.5230622161
59 (in isoform 2)Phosphorylation-8.8120068231
65PhosphorylationFYRQLLLTADDRVNP
HHHHHHHCCCCCCCH
28.1920068231
69MethylationLLLTADDRVNPCIGG
HHHCCCCCCCHHHCC
30.57-
71PhosphorylationLTADDRVNPCIGGVI
HCCCCCCCHHHCCEE
26.9827251275
73S-nitrosocysteineADDRVNPCIGGVILF
CCCCCCHHHCCEEEE
3.68-
73S-nitrosylationADDRVNPCIGGVILF
CCCCCCHHHCCEEEE
3.6822178444
73S-palmitoylationADDRVNPCIGGVILF
CCCCCCHHHCCEEEE
3.6829575903
83PhosphorylationGVILFHETLYQKADD
CEEEEEEHHHHHCCC
23.3822673903
85PhosphorylationILFHETLYQKADDGR
EEEEEHHHHHCCCCC
18.5222673903
87AcetylationFHETLYQKADDGRPF
EEEHHHHHCCCCCCC
39.9825953088
87UbiquitinationFHETLYQKADDGRPF
EEEHHHHHCCCCCCC
39.98-
90PhosphorylationTLYQKADDGRPFPQV
HHHHHCCCCCCCCCC
60.9227251275
91PhosphorylationLYQKADDGRPFPQVI
HHHHCCCCCCCCCCH
39.4427251275
93PhosphorylationQKADDGRPFPQVIKS
HHCCCCCCCCCCHHC
51.2927251275
96AcetylationDDGRPFPQVIKSKGG
CCCCCCCCCHHCCCC
50.3619608861
96UbiquitinationDDGRPFPQVIKSKGG
CCCCCCCCCHHCCCC
50.3619608861
99AcetylationRPFPQVIKSKGGVVG
CCCCCCHHCCCCEEE
47.4623236377
99MalonylationRPFPQVIKSKGGVVG
CCCCCCHHCCCCEEE
47.4626320211
99MethylationRPFPQVIKSKGGVVG
CCCCCCHHCCCCEEE
47.46-
99OtherRPFPQVIKSKGGVVG
CCCCCCHHCCCCEEE
47.4629775581
99UbiquitinationRPFPQVIKSKGGVVG
CCCCCCHHCCCCEEE
47.46-
100PhosphorylationPFPQVIKSKGGVVGI
CCCCCHHCCCCEEEE
25.9619764811
101MethylationFPQVIKSKGGVVGIK
CCCCHHCCCCEEEEE
55.47-
101UbiquitinationFPQVIKSKGGVVGIK
CCCCHHCCCCEEEEE
55.4721906983
108SumoylationKGGVVGIKVDKGVVP
CCCEEEEEECCCCEE
38.15-
108AcetylationKGGVVGIKVDKGVVP
CCCEEEEEECCCCEE
38.1519608861
108MalonylationKGGVVGIKVDKGVVP
CCCEEEEEECCCCEE
38.1526320211
108SumoylationKGGVVGIKVDKGVVP
CCCEEEEEECCCCEE
38.1519608861
108UbiquitinationKGGVVGIKVDKGVVP
CCCEEEEEECCCCEE
38.1521890473
111N6-malonyllysineVVGIKVDKGVVPLAG
EEEEEECCCCEECCC
57.50-
111AcetylationVVGIKVDKGVVPLAG
EEEEEECCCCEECCC
57.5023954790
111MalonylationVVGIKVDKGVVPLAG
EEEEEECCCCEECCC
57.5026320211
111UbiquitinationVVGIKVDKGVVPLAG
EEEEEECCCCEECCC
57.5021890473
119PhosphorylationGVVPLAGTNGETTTQ
CCEECCCCCCCCCCC
34.1521601212
123PhosphorylationLAGTNGETTTQGLDG
CCCCCCCCCCCCCCH
36.2225627689
124PhosphorylationAGTNGETTTQGLDGL
CCCCCCCCCCCCCHH
16.9025627689
125PhosphorylationGTNGETTTQGLDGLS
CCCCCCCCCCCCHHH
28.2325627689
132PhosphorylationTQGLDGLSERCAQYK
CCCCCHHHHHHHHHH
28.6425159151
134MethylationGLDGLSERCAQYKKD
CCCHHHHHHHHHHHC
20.07-
138PhosphorylationLSERCAQYKKDGADF
HHHHHHHHHHCCHHH
11.07-
139AcetylationSERCAQYKKDGADFA
HHHHHHHHHCCHHHH
32.1022361385
139UbiquitinationSERCAQYKKDGADFA
HHHHHHHHHCCHHHH
32.10-
140UbiquitinationERCAQYKKDGADFAK
HHHHHHHHCCHHHHE
57.3621906983
147AcetylationKDGADFAKWRCVLKI
HCCHHHHEEEEEEEE
34.8521466224
147MalonylationKDGADFAKWRCVLKI
HCCHHHHEEEEEEEE
34.8526320211
147UbiquitinationKDGADFAKWRCVLKI
HCCHHHHEEEEEEEE
34.85-
153AcetylationAKWRCVLKIGEHTPS
HEEEEEEEECCCCHH
28.4123954790
153UbiquitinationAKWRCVLKIGEHTPS
HEEEEEEEECCCCHH
28.4121890473
158PhosphorylationVLKIGEHTPSALAIM
EEEECCCCHHHHHHH
18.0328450419
160PhosphorylationKIGEHTPSALAIMEN
EECCCCHHHHHHHHC
36.7528450419
162AcetylationGEHTPSALAIMENAN
CCCCHHHHHHHHCHH
3.7819608861
162UbiquitinationGEHTPSALAIMENAN
CCCCHHHHHHHHCHH
3.7819608861
165SulfoxidationTPSALAIMENANVLA
CHHHHHHHHCHHHHH
2.4321406390
174PhosphorylationNANVLARYASICQQN
CHHHHHHHHHHHHHC
10.0928450419
176PhosphorylationNVLARYASICQQNGI
HHHHHHHHHHHHCCC
18.2481018241
178S-palmitoylationLARYASICQQNGIVP
HHHHHHHHHHCCCCC
2.9329575903
186PhosphorylationQQNGIVPIVEPEILP
HHCCCCCCCCCCCCC
3.6727251275
200AcetylationPDGDHDLKRCQYVTE
CCCCCCHHHHHHHHH
58.1323954790
200SuccinylationPDGDHDLKRCQYVTE
CCCCCCHHHHHHHHH
58.1323954790
200UbiquitinationPDGDHDLKRCQYVTE
CCCCCCHHHHHHHHH
58.13-
204PhosphorylationHDLKRCQYVTEKVLA
CCHHHHHHHHHHHHH
16.9921082442
206PhosphorylationLKRCQYVTEKVLAAV
HHHHHHHHHHHHHHH
25.7528152594
208AcetylationRCQYVTEKVLAAVYK
HHHHHHHHHHHHHHH
32.9325953088
208UbiquitinationRCQYVTEKVLAAVYK
HHHHHHHHHHHHHHH
32.9321890473
212PhosphorylationVTEKVLAAVYKALSD
HHHHHHHHHHHHHCC
10.8727251275
214PhosphorylationEKVLAAVYKALSDHH
HHHHHHHHHHHCCCC
5.947998215
215MethylationKVLAAVYKALSDHHI
HHHHHHHHHHCCCCE
35.93-
215UbiquitinationKVLAAVYKALSDHHI
HHHHHHHHHHCCCCE
35.93-
218PhosphorylationAAVYKALSDHHIYLE
HHHHHHHCCCCEEEE
39.4927259358
223PhosphorylationALSDHHIYLEGTLLK
HHCCCCEEEECEEEC
8.3727155012
227PhosphorylationHHIYLEGTLLKPNMV
CCEEEECEEECCCCC
21.3925693802
230AcetylationYLEGTLLKPNMVTPG
EEECEEECCCCCCCC
37.1423954790
230PhosphorylationYLEGTLLKPNMVTPG
EEECEEECCCCCCCC
37.1427251275
230UbiquitinationYLEGTLLKPNMVTPG
EEECEEECCCCCCCC
37.1419608861
235PhosphorylationLLKPNMVTPGHACTQ
EECCCCCCCCCCCCC
16.8819060867
240S-nitrosocysteineMVTPGHACTQKFSHE
CCCCCCCCCCCCCHH
3.25-
240S-nitrosylationMVTPGHACTQKFSHE
CCCCCCCCCCCCCHH
3.2522178444
241PhosphorylationVTPGHACTQKFSHEE
CCCCCCCCCCCCHHH
35.2619060867
243AcetylationPGHACTQKFSHEEIA
CCCCCCCCCCHHHHH
30.5925953088
251SulfoxidationFSHEEIAMATVTALR
CCHHHHHHHHHHHHH
3.8421406390
253PhosphorylationHEEIAMATVTALRRT
HHHHHHHHHHHHHHH
12.81-
255PhosphorylationEIAMATVTALRRTVP
HHHHHHHHHHHHHCC
18.6726437602
258PhosphorylationMATVTALRRTVPPAV
HHHHHHHHHHCCCCC
29.7527251275
260PhosphorylationTVTALRRTVPPAVTG
HHHHHHHHCCCCCCE
30.8130278072
266PhosphorylationRTVPPAVTGITFLSG
HHCCCCCCEEEEECC
25.6030278072
269PhosphorylationPPAVTGITFLSGGQS
CCCCCEEEEECCCCC
21.6226657352
272PhosphorylationVTGITFLSGGQSEEE
CCEEEEECCCCCHHH
36.3630278072
276PhosphorylationTFLSGGQSEEEASIN
EEECCCCCHHHHEEE
50.6930278072
281PhosphorylationGQSEEEASINLNAIN
CCCHHHHEEECCHHC
18.4522199227
284AcetylationEEEASINLNAINKCP
HHHHEEECCHHCCCC
4.3419608861
284UbiquitinationEEEASINLNAINKCP
HHHHEEECCHHCCCC
4.3419608861
290S-palmitoylationNLNAINKCPLLKPWA
ECCHHCCCCCCCCEE
2.1929575903
294AcetylationINKCPLLKPWALTFS
HCCCCCCCCEEEEEE
46.3125953088
294MethylationINKCPLLKPWALTFS
HCCCCCCCCEEEEEE
46.3123644510
294UbiquitinationINKCPLLKPWALTFS
HCCCCCCCCEEEEEE
46.3121906983
299PhosphorylationLLKPWALTFSYGRAL
CCCCEEEEEEHHHHH
11.6428152594
301PhosphorylationKPWALTFSYGRALQA
CCEEEEEEHHHHHHH
22.8028152594
302PhosphorylationPWALTFSYGRALQAS
CEEEEEEHHHHHHHH
13.3628152594
309PhosphorylationYGRALQASALKAWGG
HHHHHHHHHHHHCCC
22.6030266825
312N6-malonyllysineALQASALKAWGGKKE
HHHHHHHHHCCCCHH
41.64-
312AcetylationALQASALKAWGGKKE
HHHHHHHHHCCCCHH
41.6423954790
312MalonylationALQASALKAWGGKKE
HHHHHHHHHCCCCHH
41.6426320211
312MethylationALQASALKAWGGKKE
HHHHHHHHHCCCCHH
41.64-
312UbiquitinationALQASALKAWGGKKE
HHHHHHHHHCCCCHH
41.6421890473
317UbiquitinationALKAWGGKKENLKAA
HHHHCCCCHHHHHHH
53.64-
318UbiquitinationLKAWGGKKENLKAAQ
HHHCCCCHHHHHHHH
55.9221906983
322AcetylationGGKKENLKAAQEEYV
CCCHHHHHHHHHHHH
53.9423954790
322MalonylationGGKKENLKAAQEEYV
CCCHHHHHHHHHHHH
53.9426320211
322MethylationGGKKENLKAAQEEYV
CCCHHHHHHHHHHHH
53.94-
322UbiquitinationGGKKENLKAAQEEYV
CCCHHHHHHHHHHHH
53.9421890473
326PhosphorylationENLKAAQEEYVKRAL
HHHHHHHHHHHHHHH
46.7127251275
328PhosphorylationLKAAQEEYVKRALAN
HHHHHHHHHHHHHHH
15.5428152594
330AcetylationAAQEEYVKRALANSL
HHHHHHHHHHHHHHH
30.9319608861
330MethylationAAQEEYVKRALANSL
HHHHHHHHHHHHHHH
30.9324129315
330UbiquitinationAAQEEYVKRALANSL
HHHHHHHHHHHHHHH
30.9321890473
336PhosphorylationVKRALANSLACQGKY
HHHHHHHHHHHCCCC
16.2528450419
339S-nitrosocysteineALANSLACQGKYTPS
HHHHHHHHCCCCCCC
7.13-
339GlutathionylationALANSLACQGKYTPS
HHHHHHHHCCCCCCC
7.1322555962
339S-nitrosylationALANSLACQGKYTPS
HHHHHHHHCCCCCCC
7.1322178444
339S-palmitoylationALANSLACQGKYTPS
HHHHHHHHCCCCCCC
7.1329575903
342AcetylationNSLACQGKYTPSGQA
HHHHHCCCCCCCCCH
21.7725953088
342UbiquitinationNSLACQGKYTPSGQA
HHHHHCCCCCCCCCH
21.772189047
343PhosphorylationSLACQGKYTPSGQAG
HHHHCCCCCCCCCHH
30.6128152594
344PhosphorylationLACQGKYTPSGQAGA
HHHCCCCCCCCCHHC
17.9228152594
346PhosphorylationCQGKYTPSGQAGAAA
HCCCCCCCCCHHCCC
35.4228152594
354O-linked_GlycosylationGQAGAAASESLFVSN
CCHHCCCCHHHCCCC
24.0031492838
354PhosphorylationGQAGAAASESLFVSN
CCHHCCCCHHHCCCC
24.0017287340
356PhosphorylationAGAAASESLFVSNHA
HHCCCCHHHCCCCCC
25.3117287340
360PhosphorylationASESLFVSNHAY---
CCHHHCCCCCCC---
18.6325693802
363PhosphorylationSLFVSNHAY------
HHCCCCCCC------
18.9127251275
364PhosphorylationLFVSNHAY-------
HCCCCCCC-------
16.1325693802
384Acetylation---------------------------
---------------------------
19608861
384Ubiquitination---------------------------
---------------------------
19608861
400Phosphorylation-------------------------------------------
-------------------------------------------
27251275
414Phosphorylation---------------------------------------------------------
---------------------------------------------------------
27251275
418Phosphorylation-------------------------------------------------------------
-------------------------------------------------------------
27642862

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of ALDOA_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of ALDOA_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of ALDOA_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
PGK1_HUMANPGK1physical
22939629
ALDOC_HUMANALDOCphysical
22939629
CH60_HUMANHSPD1physical
22939629
LEG1_HUMANLGALS1physical
22939629
ALDOB_HUMANALDOBphysical
21988832
ALDOA_HUMANALDOAphysical
21988832
BCAT2_HUMANBCAT2physical
21988832
GALT6_HUMANGALNT6physical
21988832
PIAS4_HUMANPIAS4physical
21988832
CISY_HUMANCSphysical
22863883
TNPO3_HUMANTNPO3physical
22863883
ALDOA_HUMANALDOAphysical
25416956
ALDOC_HUMANALDOCphysical
25416956
IFNA4_HUMANIFNA4physical
25416956
THIM_HUMANACAA2physical
26344197
ACTN4_HUMANACTN4physical
26344197
ATP5J_HUMANATP5Jphysical
26344197
KCRB_HUMANCKBphysical
26344197
KCRU_HUMANCKMT1Bphysical
26344197
KCRS_HUMANCKMT2physical
26344197
DUT_HUMANDUTphysical
26344197
ENOA_HUMANENO1physical
26344197
FABP5_HUMANFABP5physical
26344197
FUMH_HUMANFHphysical
26344197
FKBP7_HUMANFKBP7physical
26344197
G3P_HUMANGAPDHphysical
26344197
LGUL_HUMANGLO1physical
26344197
CH10_HUMANHSPE1physical
26344197
KCAB2_HUMANKCNAB2physical
26344197
LDHA_HUMANLDHAphysical
26344197
LKHA4_HUMANLTA4Hphysical
26344197
NDUS4_HUMANNDUFS4physical
26344197
PGAM2_HUMANPGAM2physical
26344197
PPCE_HUMANPREPphysical
26344197
SODM_HUMANSOD2physical
26344197
SUMO4_HUMANSUMO4physical
26344197
TALDO_HUMANTALDO1physical
26344197
UMPS_HUMANUMPSphysical
26344197
ALDOC_HUMANALDOCphysical
26496610
DRC1_HUMANDRC1physical
26496610
CARM1_HUMANCARM1physical
28514442

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
611881Glycogen storage disease 12 (GSD12)
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of ALDOA_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions.";
Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.;
Science 325:834-840(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-42; LYS-108 AND LYS-330, ANDMASS SPECTROMETRY.
"Substrate and functional diversity of lysine acetylation revealed bya proteomics survey.";
Kim S.C., Sprung R., Chen Y., Xu Y., Ball H., Pei J., Cheng T.,Kho Y., Xiao H., Xiao L., Grishin N.V., White M., Yang X.-J., Zhao Y.;
Mol. Cell 23:607-618(2006).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-13 AND LYS-42, AND MASSSPECTROMETRY.
Malonylation
ReferencePubMed
"The first identification of lysine malonylation substrates and itsregulatory enzyme.";
Peng C., Lu Z., Xie Z., Cheng Z., Chen Y., Tan M., Luo H., Zhang Y.,He W., Yang K., Zwaans B.M., Tishkoff D., Ho L., Lombard D., He T.C.,Dai J., Verdin E., Ye Y., Zhao Y.;
Mol. Cell. Proteomics 10:M111.012658.01-M111.012658.12(2011).
Cited for: MALONYLATION AT LYS-111 AND LYS-312.
N6-malonyllysine
ReferencePubMed
"The first identification of lysine malonylation substrates and itsregulatory enzyme.";
Peng C., Lu Z., Xie Z., Cheng Z., Chen Y., Tan M., Luo H., Zhang Y.,He W., Yang K., Zwaans B.M., Tishkoff D., Ho L., Lombard D., He T.C.,Dai J., Verdin E., Ye Y., Zhao Y.;
Mol. Cell. Proteomics 10:M111.012658.01-M111.012658.12(2011).
Cited for: MALONYLATION AT LYS-111 AND LYS-312.
Phosphorylation
ReferencePubMed
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions.";
Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.;
Sci. Signal. 2:RA46-RA46(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-36; SER-39 AND SER-46,AND MASS SPECTROMETRY.
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-9; SER-36; THR-37 ANDSER-46, AND MASS SPECTROMETRY.
"Global proteomic profiling of phosphopeptides using electron transferdissociation tandem mass spectrometry.";
Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A.;
Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-235; THR-241; SER-354AND SER-356, AND MASS SPECTROMETRY.
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks.";
Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.;
Cell 127:635-648(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-46, AND MASSSPECTROMETRY.
"Global phosphoproteome analysis on human HepG2 hepatocytes usingreversed-phase diagonal LC.";
Gevaert K., Staes A., Van Damme J., De Groot S., Hugelier K.,Demol H., Martens L., Goethals M., Vandekerckhove J.;
Proteomics 5:3589-3599(2005).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-65, AND MASSSPECTROMETRY.
"An extensive survey of tyrosine phosphorylation revealing new sitesin human mammary epithelial cells.";
Heibeck T.H., Ding S.-J., Opresko L.K., Zhao R., Schepmoes A.A.,Yang F., Tolmachev A.V., Monroe M.E., Camp D.G. II, Smith R.D.,Wiley H.S., Qian W.-J.;
J. Proteome Res. 8:3852-3861(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-364, AND MASSSPECTROMETRY.
"Global survey of phosphotyrosine signaling identifies oncogenickinases in lung cancer.";
Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J.,Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L.,Mitchell J., Wetzel R., Macneill J., Ren J.M., Yuan J.,Bakalarski C.E., Villen J., Kornhauser J.M., Smith B., Li D., Zhou X.,Gygi S.P., Gu T.-L., Polakiewicz R.D., Rush J., Comb M.J.;
Cell 131:1190-1203(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-3; TYR-5 AND TYR-223,AND MASS SPECTROMETRY.
"Immunoaffinity profiling of tyrosine phosphorylation in cancercells.";
Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,Zha X.-M., Polakiewicz R.D., Comb M.J.;
Nat. Biotechnol. 23:94-101(2005).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-204, AND MASSSPECTROMETRY.

TOP